Park Square has placed Loïc Vincent, Ph.D. as Chief Scientific Officer at Korro Bio.
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines...…
Park Square is pleased to announce the placement of Jamie Lewis as Chief Commercial Officer at Inflammatix. Inflammatix is a pioneering...
Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences.
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive...…
Park Square is pleased to announce the placement of Julia Tran at Xaira Therapeutics, where she will lead the People and Culture...
Park Square is pleased to announce the placement of Cristiana Guiducci, Ph.D., as Chief Scientific Officer at Rezo Therapeutics.
Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net